Clinical Trial Update: Evaluation of the Effect of Rosuvastatin on Cisplatin-induced Nephrotoxicity and Ototoxicity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether rosuvastatin mitigates cisplatin-induced nephrotoxicity and ototoxicity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cisplatin-induced Nephrotoxicity
• Cisplatin-induced Ototoxicity

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Cairo University | Conditions: Cisplatin Adverse Reaction | Phase 2 | Status: UNKNOWN